Abstract
Objective: The purpose of this study was to determine whether vitamin D receptor (VDR) gene polymorphisms influence risk of colorectal adenoma.
Methods: Polymorphisms in the 5′ and 3′ ends of the VDR gene were genotyped for 373 colorectal adenoma cases and 394 controls.
Results: Overall, there was no significant association between the 5′ (FokI) or the 3′ (BsmI) polymorphisms and adenoma risk. However, risk of large (>1 cm) adenomas decreased with increasing copies of the FokI f allele (p = 0.04). Compared to the FF genotype, odds ratios for the Ff and ff genotypes were 0.79 (95% CI 0.44–1.41) and 0.32 (95% CI 0.11–0.91), respectively. FokI genotype was more strongly related to large adenoma risk among subjects with low dietary calcium intake (ORFf = 0.48; 95% CI 0.17–1.3; ORff = 0.21; 95% CI 0.04–1.3), low dietary vitamin D intake (ORFf = 0.25; 95% CI 0.09–0.69; ORff = 0.22; 95% CI 0.04–1.2), or dark skin color (ORFf = 0.66; 95% CI 0.27–1.6; ORff = 0.10; 95% CI 0.01–1.0).
Conclusion: These results suggest that VDR FokI genotype influences development of colorectal adenomas, and that the effect may be modified by calcium and vitamin D status.
Similar content being viewed by others
References
Garland CF, Garland FC (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9: 227–231.
Martinez ME, Willett WC (1998) Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. [Review] Cancer Epidemiol Biomarkers Prev 7: 163–168.
Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED (1989) Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2: 1176–1178.
Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW (1995) Colon cancer and serum vitamin D metabolite levels 10–17 years prior to diagnosis. Am J Epidemiol 142: 608–611.
Tangrea J, Helzlsouer K, Pietinen P, et al. (1997) Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8: 615–662.
Studzinski GP, McLane JA, Uskokovic MR (1993) Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. [Review] Crit Rev Eukaryot Gene Exp 3: 279–312.
Lointier P, Meggouh F, Dechelotte P, et al. (1991) 1,25-Dihydroxyvitamin D3 receptors and human colon adenocarcinoma. Br J Surg 78: 435–439.
Buras RR, Schumaker LM, Davoodi F, et al. (1994) Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31: 191–202.
Pechl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D (1994) Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54: 805–810.
Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR (1993) 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 53: 3712–3718.
Cross HS, Pavelka M, Slavik J, Peterlik M (1992) Growth control of human colon cancer cells by vitamin D and calcium in vitro. J Natl Cancer Inst 84: 1355–1357.
Evans SR, Nolla J, Hanfelt J, Shabahang M, Nauta RJ, Schepotin IB (1998) Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. Clin Cancer Res 4: 1591–1595.
Cooper GS, Umbach DM (1996) Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 11: 1841–1849.
Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D (1996) The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 11: 1850–1855.
Arai H, Miyamoto K, Taketani Y, et al. (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12: 915–921.
Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D (1997) The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 12: 1043–1048.
Gennari L, Becherini L, Mansani R, et al. (1999) FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women. J Bone Miner Res 14: 1379–1386.
Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA (1996) Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 56: 4108–4110.
Ingles SA, Ross RK, Yu MC, et al. (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89: 166–170.
Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, Griffiths LR (1999) Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer 83: 723–726.
Ingles SA, Garcia DG, Wang W, et al. (2000) Vitamin D receptor genotype and breast cancer in Latinas. Cancer Causes Control 11: 25–30.
Lin H, Probst-Hensch NM, Ingles SA, et al. (1995) Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas. Cancer Res 55: 1224–1226.
Haile RW, Witte JS, Longnecker MP (1997) A sigmoidoscopy-based case control study of polyps: macronutrients, fiber and meat consumption. Int J Cancer 73: 497–502.
Morrison NA, Qi JC, Tokita A, et al. (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367: 284–287.
Lucotte G, Mercier G, Burckel A (1999) Fok I polymorphism at the human vitamin D receptor gene locus in Europeans and Africans. Clin Genet 55: 281–282.
Eccleshall TR, Garnero P, Gross C, Delmas PD, Feldman D (1998) Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY study. J Bone Miner Res 13: 31–35.
Ferrari S, Rizzoli R, Manen D, Slosman D, Bonjour JP (1998) Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3'-end region polymorphisms. J Bone Miner Res 13: 925–930.
Correa P, Rastad J, Schwarz P, et al. (1999) The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels. J Clin Endocrinol Metab 84: 1690–1694.
Zmuda JM, Cauley JA, Danielson ME, Theobald TM, Ferrell RE (1999) Vitamin D receptor translation initiation codon polymorphism and markers of osteoporotic risk in older African-American women. Osteoporosis Int 9: 214–219.
Minamitani K, Takahashi Y, Minagawa M, Yasuda T, Niimi H (1998) Difference in height associated with a translation start site polymorphism in the vitamin D receptro gene. Pediair Res 44: 628–632.
Ingles SA, Haile RW, Henderson BE, et al. (1997) Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 6: 93–98.
Ma J, Stampfer MJ, Gann PH, et al. (1998) Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 7: 385–390.
McClure L, Eccleshall TR, Gross C, et al. (1997) Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women. J Bone Miner Res 12: 234–240.
Tokita A, Matsumoto H, Morrison NA, et al. (1996) Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res 11: 1003–1009.
Williams CB, Bedenne L (1990) Management of colorectal polyps: is all the effort worthwhile? [Review]. J Gastroenterol Hepatol 5(Suppl. 1): 144–165.
Kim EC, Lance P (1997) Colorectal polyps and their relationship to cancer [Review]. Gastroenterol Clin N Am 26: 1–17.
Atkin WS, Morson BC, Cuzick J, et al. (1992) Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326: 658–662.
Saijo T, Ito M, Takeda E, et al. (1991) A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am J Hum Genet 49: 668–673.
Miyamoto K, Kesterson RA, Yamamoto H, et al. (1997) Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 8: 1165–1179.
Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D (1998) The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res 13: 1691–1699.
Jurutka PW, Remus LS, Whitfield GK, et al. (2000) The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor HB. Mol Endocrinol 14: 401–420.
Tajima O, Ashizawa N, Ishii T, et al. (2000) Interaction of the effects between vitamin D receptor polymorphism and exercise training on bone metabolism. J Appl Physiol 88: 1271–1276.
Ames SK, Ellis KJ, Gunn SK, Copeland KC, Abrams SA (1999) Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res 14: 740–746.
Hutchinson PE, Osborne JE, Lear JT, et al. (2000) Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 6: 498–504.
Wargovich MJ, Eng VW, Newmark HL (1984) Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett 23: 253–258.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ingles, S.A., Wang, J., Coetzee, G.A. et al. Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control 12, 607–614 (2001). https://doi.org/10.1023/A:1011292002475
Issue Date:
DOI: https://doi.org/10.1023/A:1011292002475